Department of Anesthesia, University Children's Hospital, Zurich, Switzerland.
Department of Intensive Care, University Hospital and University of Zurich, Zurich, Switzerland.
Paediatr Anaesth. 2023 Dec;33(12):1099-1107. doi: 10.1111/pan.14750. Epub 2023 Sep 5.
Connection and opening a syringe infusion pump to a central venous line can lead to acute anterograde or retrograde fluid shifts depending on the level of central venous pressure. This may lead to bolus events or to prolonged lag times of intravenous drug delivery, being particularly relevant when administering vasoactive or inotropic drugs in critically ill patients using microinfusion. The aim of this study was to assess the effect of syringe pump positioning at different vertical heights on start-up fluid delivery before versus after purging and connection the pump to the central venous catheter.
This in vitro study measured ante- and retrograde infusion volumes delivered to the central venous line after starting the syringe pump at a set infusion rate of 1 mL/h. In setup one, the pump was first positioned to vertical levels of +43 cm or -43 cm and then purged and connected to a central venous catheter. In setup two, the pump was first purged and connected at zero level and secondarily positioned to a vertical level of +43 cm or -43 cm. Central venous pressure was adjusted to 10 mmHg in both setups.
Positioning of the pump prior to purging and connection to the central venous catheter resulted in a better start-up performance with delivered fluid closer to programmed and expected infusion volumes when compared to the pump first purged, connected, and then positioned. Significant backflow volumes were observed with the pump purged and connected first and then positioned below zero level. No backflow was measured with the pump positioned first below zero level and then purged and connected.
Syringe infusion pump assemblies should be positioned prior to purging and connection to a central venous catheter line when starting a new drug, particularly when administering highly concentrated vasoactive or inotropic drugs delivered at low flow rates.
根据中心静脉压的水平,注射器输注泵与中心静脉导管连接和开启可能导致急性顺行或逆行液体转移。这可能导致推注事件或静脉内药物输送的延长滞后时间,当在使用微输注对危重病患者给予血管活性或正性肌力药物时尤其相关。本研究的目的是评估在不同垂直高度下对注射器泵的定位对开始输注前与冲洗和连接到中心静脉导管后的启动流体输送的影响。
本体外研究测量在设定输注速率为 1mL/h 的情况下,注射器泵开始后输送到中心静脉线的顺行和逆行输注量。在设置 1 中,首先将泵定位到+43cm 或-43cm 的垂直水平,然后冲洗并连接到中心静脉导管。在设置 2 中,首先冲洗并连接到零水平,然后将泵定位到+43cm 或-43cm 的垂直水平。在两个设置中均将中心静脉压调节至 10mmHg。
与先冲洗、连接、然后定位相比,在冲洗和连接到中心静脉导管之前定位泵可使启动性能更好,输送的液体更接近编程和预期的输注量。当泵先冲洗、连接,然后定位在零水平以下时,观察到显著的回流体积。当泵先定位在零水平以下,然后冲洗和连接时,未测量到回流。
当开始新药物时,特别是在以低流速给予高浓度血管活性或正性肌力药物时,注射器输注泵组件应在冲洗和连接到中心静脉导管线之前定位。